Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Head and Neck Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cancer, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, kidney cancer, kidney disorder, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, squamous cell carcinoma, triple-negative breast carcinoma, urinary system disorder	Recruiting	Phase 1 / Phase 2	2024-11-15		NCT04787042

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Merck Sharp & Dohme LLC	650
Simcha IL-18, Inc.	1

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
HonorHealth Research Institute	Scottsdale	United States	36
Massachusetts General Hospital	Boston	United States	1015
Moffitt Cancer Center	Tampa	United States	523
Roswell Park Cancer Institute	Buffalo	United States	382
Sarah Cannon Research Institute at HealthOne	Denver	United States	34
Yale Cancer Center	New Haven	United States	15